Showing results (201-210 of 296) with videos related to

Sort By:
Pageof 30
American Journal of Hematology|July 1, 1995
Idiopathic CD4+ T-lymphocytopenia in HIV seronegative men with hemophilia and sex partners of HIV seropositive men. Multicenter Hemophilia Cohort StudyT R O'Brien, L Diamondstone, M W Fried, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2021
Factors Associated With Readmission in the United States Following Hospitalization With Coronavirus Disease 2019Elizabeth C Verna, Charles Landis, Robert S Brown, et al.
Hepatology (Baltimore, Md.)|May 1, 1997
Hepatitis G virus co-infection in liver transplantation recipients with chronic hepatitis C and nonviral chronic liver diseaseM W Fried, Y E Khudyakov, G A Smallwood, et al.
Hepatology (Baltimore, Md.)|January 15, 2013
A global view of hepatitis C: physician knowledge, opinions, and perceived barriers to careChristopher E McGowan, Ali Monis, Bruce R Bacon, et al.
Hepatology (Baltimore, Md.)|October 12, 2007
Hepatic gene expression during treatment with peginterferon and ribavirin: Identifying molecular pathways for treatment responseJordan J Feld, Santosh Nanda, Ying Huang, et al.
Alimentary Pharmacology & Therapeutics|July 16, 2025
The Magnitude of Polypharmacy and Role of Disease Severity and Patient Sex in Medication Use Among Patients With MASLD Enrolled in TARGET-NASHBrent A Neuschwander-Tetri, Heather L Morris, Andrea R Mospan, et al.
Gut|October 10, 2015
Hepatitis C virus treatment in the real world: optimising treatment and access to therapiesFabien Zoulim, T Jake Liang, Alexander L Gerbes, et al.
Hepatitis Research and Treatment|October 25, 2012
Hepatitis C virus: a critical appraisal of new approaches to therapyDavid R Nelson, Donald M Jensen, Mark S Sulkowski, et al.
The American Journal of Gastroenterology|November 1, 1993
A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis BA M Di Bisceglie, T L Fong, M W Fried, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 8, 2015
Ombitasvir/paritaprevir/r, dasabuvir and ribavirin for cirrhotic HCV patients with thrombocytopaenia and hypoalbuminaemiaXavier Forns, Fred Poordad, Marcos Pedrosa, et al.
Pageof 30